We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKIN.L Regulatory News (SKIN)

  • There is currently no data for SKIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3-year Rev sharing Framework Ag with Parity Group

19 Dec 2019 07:00

RNS Number : 3971X
Integumen PLC
19 December 2019
 

AIM share code: SKIN

 

19 December 2019

 

Integumen PLC

 

("Integumen" or "Company")

 

Integumen signs 3-year revenue sharing Framework Agreement with Parity Group plc

 

 

Further to the announcement of 13 November 2019, Rinocloud Limited ("Rinocloud"), a subsidiary of Integumen has signed a 3-year Framework Agreement ("Agreement") with Parity Professionals Limited ("Parity"), a subsidiary of Parity Group plc. The Agreement is for the supply and roll-out of mobile enterprise resource, data management and business tool software services to clients from the National Health Service ("NHS"), Public Sector, Utilities, Housing Associations and Private Institutional companies.

 

Gerard Brandon, CEO of Integumen, & Director of Rinocloud, comments:

"Following on from the Heads of Terms signed with Parity announced five weeks ago, the Parity Team offers Rinocloud a vendor approved, ready-made sales, marketing and distribution channel into the ideal clients for its mobile enterprise resource and data management software services. The teams have jointly identified a number of clients across the Parity client portfolio who would benefit from working with Rinocloud and we will initiate consultations with them early in 2020."

 

Matthew Bayfield, CEO of Parity Group plc, & Director of Parity Professionals Ltd., comments:

"Our Agreement with Rinocloud is a complementary combination of Parity Professional people and Rinocloud software services who are set to define, develop and deploy value-added mobile enterprise resource and data management solutions across our public sector and private institutional clients. By increasing value for our clients, we increase our revenue per client, increase client contract terms, generating a higher margin and profitability."

 

Combined benefits:

·; Recurring shared revenue streams for both Parity and Integumen in 2020

·; Value-added proposition in demand from Parity clients with c. 3 to 5-year annual contracts

·; Immediate access to 150 public and private institutional clients

·; Trusted approved vendor for Government and private sectors for over 45 years

·; 1,000+ data experts and 100+ enterprise sales and office professionals

·; Existing cross-over access to educational institutional research facilities

·; Access to multiple industry, public and private sector distribution routes to market

·; Well defined roadmap to next level business growth for both Parity and Integumen

 

 

Contacts

 

Integumen plc

Gerard Brandon, CEO

 

+44 (0) 7340 055 648

SPARK Advisory Partners Limited

(Nominated Adviser)

 

Neil Baldwin/Andrew Emmott

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/Zoe Alexander

+44 (0) 20 3657 0050

 

About Integumen: www.integumen.com

Integumen is a vertically integrated product and services company for skin related diseases, treatments and therapies with four business units:

 

·; Labskin AI's technology platform incorporates artificial intelligence within clinical research for medical device, pharmaceuticals, cosmeceuticals and related life science test services. Labskin allows skincare, healthcare, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple state-of-the-art partner technologies.

·; Rinodrive is a data aggregation, refining and AI analysis open-source eco-system designed to provide third-party service providers the ability to offer their clients valuable insights that support clinical, operational and financial decisions in healthcare services, third-level education, government departments and the financial sector.

·; Wound pHase is developing skin and wound care products using its proprietary wound dressing technology. Working in collaboration with CBD providers creating a CBD infused diabetic wound care product range.

·; Stoer-for-men skin products e-commerce division offers a range of skincare products derived from 5 natural super-ingredient plant extracts specifically for men to reduce the signs of ageing and is also used as a control for client testing within Labskin laboratories.

 

About Parity Group plc: www.parity.net

Parity helps organisations find the right people, skills and data to support data-led business decisions. Providing advice on data and with access to qualified personnel with skills offered, either as a managed service, through resourcing in the contract or permanent market or as part of a learning and development programme.

Income derives from a mix of long-term contracts with public and private sector organisations as well as expanded projects with existing clients as a result of strong relationships and a track record of high client satisfaction. Key highlights comprising of:

·; Over 45 years of expertise in public and private recruitment and service contract sector

·; More than 100 employees across the UK

·; Client numbers exceed 150 in both UK and Ireland

·; Associate numbers supporting client services exceeds 1,000

 

Rinocloud: www.rinodrive.com

A fully integrated set of software tools that can ingest data, in any volume, from any source in any format, interact with it, learn from it and enrich it to unlock insights and discoveries.

This data management solution was developed by scientists and engineers with experience in software, sensors, AI, optofluidic research, fintech, green-tech, travel and healthcare.

It was designed to allow interaction, in a cyber-secure environment, with commercially sensitive data, and to share insights across multi-disciplinary teams, generating different data formats, from multiple sources, located in different countries.

RinoDrive delivers big data, AI functionality and world class infrastructure to large companies with big data problems. These include financial services, education and life science companies. Most recently completing the automation of laboratories and application of AI to unearth more knowledge about the skin microbiome. This led to the acquisition in May 2019 by Integumen, to secure access to, and the exploitation of data from some of the largest cosmetic, pharmaceutical and medical companies in the world.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFFWFWAFUSELE
Date   Source Headline
7th Sep 20202:08 pmRNSForm 8.3 - Integumen plc
7th Sep 202012:30 pmRNSRule 2.9 Announcement - update
4th Sep 20205:31 pmRNSForm 8.3 - Integumen plc
4th Sep 20205:31 pmRNSForm 8.3 - Integumen plc
4th Sep 20203:36 pmRNSForm 8.3 - Integumen PLC
3rd Sep 20203:56 pmRNSForm 8.3 - Integumen plc
3rd Sep 202011:05 amRNSSecond Price Monitoring Extn
3rd Sep 202011:02 amGNWForm 8.3 - Integumen Plc
3rd Sep 202011:00 amRNSPrice Monitoring Extension
2nd Sep 202010:50 amRNSForm 8.3 - Integumen plc
2nd Sep 20207:18 amRNSForm 8.3 - Integumen plc
1st Sep 20205:35 pmRNSNotice of AGM
1st Sep 20204:40 pmRNSSecond Price Monitoring Extn
1st Sep 20204:35 pmRNSPrice Monitoring Extension
1st Sep 202012:05 pmGNWForm 8.3 - Integumen Plc
28th Aug 20204:49 pmRNSRule 2.9 Announcement
28th Aug 20202:45 pmRNSExercise of Warrants; Total Voting Rights
28th Aug 202011:05 amRNSSecond Price Monitoring Extn
28th Aug 202011:00 amRNSPrice Monitoring Extension
28th Aug 20208:06 amRNSRECOMMENDED ALL-EQUITY OFFER FOR MODERN WATER PLC
26th Aug 20204:41 pmRNSSecond Price Monitoring Extn
26th Aug 20204:35 pmRNSPrice Monitoring Extension
26th Aug 20201:30 pmRNSExercise of Warrants; Total Voting Rights
24th Aug 20202:37 pmRNSExercise of Warrants
21st Aug 20202:06 pmRNSSecond Price Monitoring Extn
21st Aug 20202:00 pmRNSPrice Monitoring Extension
14th Aug 20207:00 amRNSExercise of Warrants; Total Voting Rights
7th Aug 20205:17 pmRNSExercise of Warrants; Total Voting Rights
29th Jul 20207:00 amRNSIntegumen secures £3 million funding facility
24th Jul 20207:00 amRNSLabskin launches remote clinical skin trials
13th Jul 20207:00 amRNSPartners with Avacta for novel SARS-CoV-2 sensors
22nd Jun 20202:06 pmRNSSecond Price Monitoring Extn
22nd Jun 20202:00 pmRNSPrice Monitoring Extension
22nd Jun 20207:00 amRNSIntegumen COVID-19 MTA signed with Aptamer Group
15th Jun 20207:01 amRNSUnsecured Loan Facility Agreement with Cellulac
15th Jun 20207:00 amRNSFinal Results
5th Jun 20207:00 amRNSExercise of Warrants; Total Voting Rights
3rd Jun 20207:00 amRNSLabskin anti-viral COVID19 skin and dental tests
1st Jun 202011:06 amRNSSecond Price Monitoring Extn
1st Jun 202011:00 amRNSPrice Monitoring Extension
29th May 202010:49 amRNSReplacement:Exercise of Warrants;TVR
28th May 20203:30 pmRNSExercise of Warrants; Total voting rights
27th May 20202:06 pmRNSSecond Price Monitoring Extn
27th May 20202:00 pmRNSPrice Monitoring Extension
11th May 20202:05 pmRNSSecond Price Monitoring Extn
11th May 20202:00 pmRNSPrice Monitoring Extension
6th May 20204:41 pmRNSSecond Price Monitoring Extn
6th May 20204:36 pmRNSPrice Monitoring Extension
6th May 20207:00 amRNSDoubling of production of Modern Water reagent
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.